Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1710071204
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
440 services
Medicare patients, 2024
225
Average age 71
Drug cost, 2024
$3.8M
545 prescriptions
Company payments, 2025
$196
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria E Cabanillas was code 99215 (office e&m - established), 137 times for 90 patients. In total Maria E Cabanillas billed 440 services in 14 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 137 | 90 | $103.29 | $14K |
| 99214 Office E&M - Established | Facility | 129 | 97 | $74.39 | $9,596 |
| 99214 Office E&M - Established | Office | 40 | 36 | $102.58 | $4,103 |
| 99222 Hospital E&M - Initial | Facility | 28 | 27 | $101.34 | $2,838 |
| 99215 Office E&M - Established | Office | 23 | 20 | $130.24 | $2,996 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $133.53 | $2,804 |
| 99205 Office E&M - New | Facility | 12 | 12 | $138.94 | $1,667 |
| 99232 Hospital E&M - Subsequent | Facility | 11 | 11 | $62.49 | $687 |
By year: 2022 $33K for 408 services; 2023 $35K for 418 services; 2024 $42K for 440 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria E Cabanillas prescribed most often to Medicare patients was Levothyroxine Sodium, with 124 prescriptions and refills. In total Maria E Cabanillas wrote 545 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 124 | 362 | 64 | $1,698 |
| Lenvima Lenvatinib Mesylate | 68 | 68 | 15 | $1.6M |
| Tafinlar Dabrafenib Mesylate | 51 | 53 | 12 | $683K |
| Mekinist Trametinib Dimethyl Sulfoxide | 49 | 49 | 12 | $715K |
| Synthroid Levothyroxine Sodium | 44 | 100 | 13 | $4,029 |
| Everolimus Generic | 35 | 39 | Under 11 | $171K |
| Cotellic Cobimetinib Fumarate | 16 | 16 | Under 11 | $130K |
Brand drugs: 342 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria E Cabanillas $196 ($196 in general payments such as food, travel and fees) from 4 companies. The largest payer was Eisai Inc. with $108.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.